Patients with previous neurological diseases including ischemic or hemorrhagic stroke, or the use of antiplatelet or anticoagulant medication, were excluded because these patients were complicated with vascular risk factors including diabetes mellitus and/or hypertension that were associated with high HMGB1 level [49-52] and became the confounding variables. This evidence concerns the gene HMGB1 and Hypertension.